INVANZ is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Ertapenem Sodium.
Product ID | 0006-3843_33313e5d-c6df-44c6-9171-db706f688242 |
NDC | 0006-3843 |
Product Type | Human Prescription Drug |
Proprietary Name | INVANZ |
Generic Name | Ertapenem Sodium |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2001-11-21 |
Marketing Category | NDA / NDA |
Application Number | NDA021337 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | ERTAPENEM SODIUM |
Active Ingredient Strength | 1 g/1 |
Pharm Classes | Carbapenems [CS],Penem Antibacterial [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2001-11-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021337 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2001-11-21 |
Ingredient | Strength |
---|---|
ERTAPENEM SODIUM | 1 g/1 |
SPL SET ID: | 33f3b99b-fa82-42e0-26bf-f49891ae3d22 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0006-3843 | INVANZ | ertapenem sodium |
42023-221 | ERTAPENEM | ertapenem sodium |
44647-051 | Ertapenem | Ertapenem Sodium |
60505-6196 | Ertapenem | Ertapenem Sodium |
63323-823 | Ertapenem | Ertapenem Sodium |
68001-408 | Ertapenem | Ertapenem Sodium |
68083-351 | Ertapenem | Ertapenem Sodium |
72266-159 | Ertapenem | Ertapenem Sodium |
0143-9398 | ertapenem sodium | ertapenem sodium |
44567-820 | ertapenem sodium | ertapenem sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INVANZ 76260938 2730094 Live/Registered |
MERCK SHARP & DOHME CORP. 2001-05-23 |
INVANZ 75345479 2522920 Live/Registered |
MERCK SHARP & DOHME CORP. 1997-08-22 |